|
|
|
Insider
Information: |
Mueller Brian |
Relationship: |
|
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
81,859 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,368,863 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
81,859 |
|
|
Total
Value |
$6,368,863 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-03-15 |
71,859 |
|
0 |
Premium* |
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-05-08 |
4 |
OE |
$11.74 |
$216,967 |
D/D |
15,708 |
29,392 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
15,246 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
150 |
15,396 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-07-02 |
4 |
OE |
$17.86 |
$49,472 |
D/D |
2,770 |
18,110 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-07-10 |
4 |
OE |
$14.39 |
$35,975 |
D/D |
2,500 |
17,840 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-11-05 |
4 |
OE |
$14.39 |
$115,120 |
D/D |
8,000 |
23,340 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-11-15 |
4 |
OE |
$14.39 |
$477,085 |
D/D |
15,812 |
31,152 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2013-03-01 |
4 |
OE |
$14.39 |
$91,464 |
D/D |
5,023 |
20,317 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2013-05-02 |
4 |
OE |
$14.39 |
$70,137 |
D/D |
4,874 |
18,734 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2013-05-03 |
4 |
OE |
$21.51 |
$161,325 |
D/D |
7,500 |
16,903 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2013-05-14 |
4 |
OE |
$21.51 |
$75,285 |
D/D |
3,500 |
10,160 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2014-12-01 |
4 |
OE |
$14.39 |
$145,785 |
D/D |
6,950 |
11,543 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2014-12-02 |
4 |
OE |
$28.23 |
$141,150 |
D/D |
5,000 |
9,593 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2015-03-03 |
4 |
OE |
$28.23 |
$197,610 |
D/D |
7,000 |
15,800 |
0 |
- |
|
ANTH |
Anthera Pharmaceuticals I... |
|
|
2015-12-23 |
4 |
OE |
$2.89 |
$28,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2017-05-08 |
4 |
OE |
$21.51 |
$55,926 |
D/D |
2,600 |
16,068 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2017-06-22 |
4 |
OE |
$21.51 |
$57,453 |
D/D |
2,671 |
15,556 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2018-06-22 |
4 |
OE |
$28.23 |
$70,321 |
D/D |
2,491 |
14,866 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2018-08-07 |
4 |
OE |
$28.23 |
$70,575 |
D/D |
2,500 |
14,875 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2021-05-07 |
4 |
OE |
$28.23 |
$189,395 |
D/D |
6,709 |
38,066 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2022-08-05 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
34,226 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2022-11-23 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
32,347 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2022-12-02 |
4 |
OE |
$67.81 |
$400,079 |
D/D |
5,900 |
31,507 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2022-12-13 |
4 |
OE |
$63.10 |
$157,750 |
D/D |
2,500 |
30,246 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2023-01-13 |
4 |
OE |
$63.10 |
$157,750 |
D/D |
2,500 |
30,246 |
0 |
- |
|
136 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|